Emergency Hypersensitivities & Atopic Responses

Anaphylaxis (Pediatric)

Acute Systemic IgE-Mediated Hypersensitivity Reaction

Primary risk age: All pediatric ages (Infants and young children have unique symptom presentations)

Urgency: Emergency
Typical age: All pediatric ages (Infants and young children have unique symptom presentations)
Body system: Immunological & Allergic

Typical course: Acute symptoms resolve within minutes to hours of epinephrine administration; hospital observation is required for 4 to 12 hours.

Reviewed against AAP · CDC · WHO · NHS guidance Last reviewed 2026-06-13

1. Summary & Pathophysiology

Acute Systemic IgE-Mediated Hypersensitivity Reaction

Pathophysiology (Development Path)

Previous exposure to an allergen generates antigen-specific IgE antibodies, which bind to mast cells and basophils. Re-exposure leads to rapid cross-linking of IgE, triggering massive, systemic degranulation. This releases histamine, tryptase, and prostaglandins, causing systemic vasodilation, increased capillary permeability, and smooth muscle spasm (bronchoconstriction).

Primary Causes & Etiology

Food allergens (peanuts, tree nuts, milk, eggs, shellfish) primarily; insect stings (wasps, bees); medications (penicillins); and latex.

2. Symptom Continuum

Early Onset Signs
Generalized urticaria (hives), pruritus, warm flushing of the skin, and mild facial swelling (angioedema) within minutes of exposure.
Progressive Phase
Shortness of breath, wheezing, hoarseness, a dry "barking" cough, swelling of the tongue, abdominal pain, vomiting, and diarrhea.
Severe Indicators
Laryngeal edema causing inspiratory stridor, respiratory failure, hypotension, tachycardia, poor perfusion, hypotonia ("floppiness" in infants), and loss of consciousness (anaphylactic shock).

3. Clinical Verification

Clinical diagnosis based on the rapid onset (minutes to hours) of skin/mucosal symptoms plus respiratory compromise or cardiovascular collapse following exposure to a known or likely allergen.

4. Care & Elements Plan

Primary Care Treatment Plan

Immediately administer intramuscular Epinephrine into the anterolateral thigh. Secure the airway and give high-flow oxygen. Place the child in a recumbent position with legs elevated. Provide intravenous fluids to support blood pressure.

Home Support Elements

Carry two auto-injectors of epinephrine at all times. Train parents, caregivers, and school staff on how to recognize symptoms and use the auto-injector. Create a Food Allergy & Anaphylaxis Emergency Action Plan.

Generic Active Ingredients (No Brands)

Epinephrine (first-line active rescue ingredient for vasoconstriction and bronchodilation)
Diphenhydramine (second-line generic H1-antihistamine active ingredient for hives)
Methylprednisolone (generic active steroid to prevent biphasic reactions).

Lists active elements only. Never administer self-designed therapies.

5. Doctor Critical Lines

Critical Thresholds: When to See a Doctor

Any suspected anaphylactic reaction requires immediate administration of epinephrine and emergency transport to the nearest hospital, as symptoms can return hours later (biphasic reaction).

6. Vaccine & Prevention

Routine Prophylaxis (Prevention)

Strict avoidance of known allergens; read food labels carefully and prevent cross-contamination.

Immunization Context

No specific immunizations exist; children with egg allergies can safely receive the MMR and Influenza vaccines under standard precautions.

7. Timelines & Outlook

Active Timeline

Acute symptoms resolve within minutes to hours of epinephrine administration; hospital observation is required for 4 to 12 hours.

Expected Prognosis

Excellent if epinephrine is administered early; delayed epinephrine is the primary risk factor for fatal outcomes.

Potential Untreated Complications

Hypoxic brain injury, myocardial ischemia, biphasic anaphylaxis, and respiratory arrest.

Mild

Allergic Rhinitis (Hay Fever)

Type I IgE-Mediated Nasal Mucosal Hypersensitivity

Preschoolers through Adolescents (Rarely diagnosed before 2 years of age)

Moderate

Cow's Milk Protein Allergy (CMPA)

IgE or Non-IgE Mediated Pediatric Food Hypersensitivity

Infants (usually presenting in the first 6 months of life)